Merck Stock

• Merck, Moderna show progress on skin cancer vaccine using same technology as COVID shots

  The patient group that took the potential skin cancer vaccine and Keytruda saw a 44 per cent reduction in the risk of death or the cancer returning, the companies said.

  Health

  Dec 13, 2022
  
• COVID-19 pill developers aim to rival Pfizer, Merck treatments

  Infectious disease experts stressed that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic.

  Health

  Sep 28, 2021
  
• Advertisement
• Merck abandons 2 potential COVID-19 vaccines over weak data

  Merck was late to join the race to develop a vaccine to protect against the coronavirus.

  Health

  Jan 25, 2021